Genes predisposing to type 1 diabetes mellitus and pathophysiology: a narrative review

DOI: https://doi.org/10.13181/mji.rev.203732
Keywords: autoimmunity, hyperglycemia, insulin, pancreas, type 1 diabetes mellitus
Abstract viewed: 2313 times
PDF downloaded: 1354 times
HTML downloaded: 250 times
EPUB downloaded: 298 times

Abstract

The possibility of targeting the causal genes along with the mechanisms of pathogenically complex diseases has led to numerous studies on the genetic etiology of some diseases. In particular, studies have added more genes to the list of type 1 diabetes mellitus (T1DM) suspect genes, necessitating an update for the interest of all stakeholders. Therefore this review articulates T1DM suspect genes and their pathophysiology. Notable electronic databases, including Medline, Scopus, PubMed, and Google-Scholar were searched for relevant information. The search identified over 73 genes suspected in the pathogenesis of T1DM, with human leukocyte antigen, insulin gene, and cytotoxic T lymphocyte-associated antigen 4 accounting for most of the cases. Mutations in these genes, along with environmental factors, may produce a defective immune response in the pancreas, resulting in β-cell autoimmunity, insulin deficiency, and hyperglycemia. The mechanisms leading to these cellular reactions are gene-specific and, if targeted in diabetic individuals, may lead to improved treatment. Medical practitioners are advised to formulate treatment procedures that target these genes in patients with T1DM.

References

  1. National Institute of Diabetes and Digestive and Kidney Diseases. Type 1 diabetes: what is type 1 diabetes? [Internet]. 2017 [cited 2018 Jul 18]. Available from: https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/type-1-diabetes.

  2. Type 1 diabetes. [Internet]. 2018 [cited 2018 Oct 28]. Available from: https://www.webmd.com/diabetes/type-1-diabetes#1.

  3. Norman J. What is type 1 diabetes [Internet]. EndocrineWeb; 2018 [cited 2018 Oct 3]. Available from: https://www.endocrineweb.com/conditions/type-1-diabetes/type-1-diabetes.

  4. Bennington-Castro J. What Is type 1 diabetes? [Internet]. Everyday Health. 2015. [cited 2018 Sep 3]. Available from https://www.everydayhealth.com/type-1-diabetes/guide/.

  5. Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778-86. https://doi.org/10.1001/jama.2014.3201

  6. Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun. 2002;3(5):235-49. https://doi.org/10.1038/sj.gene.6363875

  7. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33(2):177-82. https://doi.org/10.1038/ng1071

  8. Bacchetta R, Maccari ME. Type 1 diabetes mellitus in monogenic autoimmune diseases. In: Barbetti F, Ghizzoni L, Guaraldi F, editors. Diabetes associated with single gene defects and chromosomal abnormalities. vol 25th. Basel: Karger; 2017. p. 78-90. https://doi.org/10.1159/000454703

  9. Baxter AG, Jordan MA. From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era. Rev Diabet Stud. 2012;9(4):201-23. https://doi.org/10.1900/RDS.2012.9.201

  10. Giliani S, Mori L, de Saint Basile G, Le Deist F, Rodriguez-Perez C, Forino C, et al. Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev. 2005;203:110-26. https://doi.org/10.1111/j.0105-2896.2005.00234.x

  11. Hulme MA, Wasserfall CH, Atkinson MA, Brusko TM. Central role for interleukin-2 in type 1 diabetes. Diabetes. 2012;61(1):14-22. https://doi.org/10.2337/db11-1213

  12. del-Rio ML, Bernhardt G, Rodriguez-Barbosa JI, Förster R. Development and functional specialization of CD103+ dendritic cells. Immunol Rev. 2010;234(1):268-81. https://doi.org/10.1111/j.0105-2896.2009.00874.x

  13. Hotta-Iwamura C, Tarbell KV. Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment. J Leukoc Biol. 2016;100(1):65-80. https://doi.org/10.1189/jlb.3MR1115-500R

  14. Daley SR, Coakley KM, Hu DY, Randall KL, Jenne CN, Limnander A, et al. Rasgrp1 mutation increases naive T-cell CD44 expression and drives mTOR-dependent accumulation of Helios+ T cells and autoantibodies. Elife. 2013;2:e01020. https://doi.org/10.7554/eLife.01020

  15. Boehm BO, Bluestone JA. Differential roles of costimulatory signaling pathways in type 1 diabetes mellitus. Rev Diabet Stud. 2004;1(4):156-64. https://doi.org/10.1900/RDS.2004.1.156

  16. Tiittanen M, Huupponen JT, Knip M, Vaarala O. Insulin treatment in patients with type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro. Diabetes. 2006;55(12):3446-54. https://doi.org/10.2337/db06-0132

  17. Jiang Z, Handler ES, Rossini AA, Woda BA. Immunopathology of diabetes in the RT6-depleted diabetes-resistant BB/Wor rat. Am J Pathol. 1990;137(4):767-77.

  18. Ge Y, Paisie TK, Newman JRB, McIntyre LM, Concannon P. UBASH3A mediates risk for type 1 diabetes through inhibition of T-cell receptor-induced NF-κB signaling. Diabetes. 2017;66(7):2033-43. https://doi.org/10.2337/db16-1023

  19. Fung EY, Smyth DJ, Howson JM, Cooper JD, Walker NM, Stevens H, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun. 2009;10(2):188-91. https://doi.org/10.1038/gene.2008.99

  20. Noble JA, Erlich HA. Genetics of type 1 diabetes. Cold Spring Harb Perspect Med. 2012;2:a007732. https://doi.org/10.1101/cshperspect.a007732

  21. Visperas A, Vignali DA. Are Tregs defective in type 1 diabetes and can we fix them? J Immunol. 2016;197(10):3762-70. https://doi.org/10.4049/jimmunol.1601118

  22. Sánchez-Zamora YI, Rodriguez-Sosa M. The role of MIF in type 1 and type 2 diabetes mellitus. J Diabetes Res. 2014;2014:804519. https://doi.org/10.1155/2014/804519

  23. Mattana TC, Santos AS, Fukui RT, Mainardi-Novo DT, Costa VS, Santos RF, et al. CD226 rs763361 is associated with the susceptibility to type 1 diabetes and greater frequency of GAD65 autoantibody in a Brazilian cohort. Mediators Inflamm. 2014;694948. https://doi.org/10.1155/2014/694948

  24. Gardner A. IL6 (Interleukin 6) [Internet]. 2018 [cited 2018 Nov 3]. Available from: https://www.mygenefood.com/genes/il6/.

  25. Guo B. IL-10 modulates Th17 pathogenicity during autoimmune diseases. J Clin Cell Immunol. 2016;7(2):400. https://doi.org/10.4172/2155-9899.1000400

  26. Bergholdt R, Ghandil P, Johannesen J, Kristiansen OP, Kockum I, Luthman H, et al. Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes. J Med Genet. 2004;41(4):e39. https://doi.org/10.1136/jmg.2003.010454

  27. Stene LC, Barriga K, Hoffman MK, Kean J, Klingensmith G, Norris JM, et al. Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). Pediatr Diabetes. 2006;7(5):247-53. https://doi.org/10.1111/j.1399-5448.2006.00198.x

  28. Iyer A, Lanham-Newusan S, Khoja S, Al-Ghamdi M, Al Doghaither H. Relationship between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Saudi patients. Int J Pharmacol. 2017;13(8):1092-7. https://doi.org/10.3923/ijp.2017.1092.1097

  29. Meller S, Di Domizio J, Voo KS, Friedrich HC, Chamilos G, Ganguly D, et al. T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26. Nature Immunol. 2015;16(9):970-9. https://doi.org/10.1038/ni.3211

  30. Liao W, Spolski R, Li P, Du N, West EE, Ren M, et al. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc Natl Acad Sci U S A. 2014;111(9):3508-13. https://doi.org/10.1073/pnas.1301138111

  31. Izumi, K, Mine K, Inoue Y, Teshima M, Ogawa S, Kai Y, et al. Reduced Tyk2 gene expression in β-cells due to natural mutation determines susceptibility to virus-induced diabetes. Nat Commun. 2015;6:6748. https://doi.org/10.1038/ncomms7748

  32. Kibirige D, Lumu W, Jones AG, Smeeth L, Hattersley AT, Nyirenda MJ. Understanding the manifestation of diabetes in sub Saharan Africa to inform therapeutic approaches and preventive strategies: a narrative review. Clin Diabetes Endocrinol. 2019;5:2. https://doi.org/10.1186/s40842-019-0077-8

  33. National Center for Biotechnology Information, U.S. National Library of Medicine. OAS1 2'-5'-oligoadenylate synthetase 1 [Homo sapiens (human)] [Internet]. Bethesda: National Center for Biotechnology Information, U.S. National Library of Medicine; 2018 [cited 2018 Jun 3]. Available from: https://www.ncbi.nlm.nih.gov/gene/4938.

  34. Mehers KL, Gillespie KM. The genetic basis for type 1 diabetes. British Med Bull. 2008; 88 (1):115-29. https://doi.org/10.1093/bmb/ldn045

  35. Yang P, Li HL, Wang CY. FUT2 nonfunctional variant: a "missing link" between genes and environment in type 1 diabetes? Diabetes. 2011;60(11):2685-7. https://doi.org/10.2337/db11-1104

  36. Brix L. Gene defect causes type 1 diabetes [Internet]. 2013 [cited 2018 Mar 15]. Available from: http://sciencenordic.com/gene-defect-causes-type-1-diabetes.

  37. Lemos NE, Dieter C, Dorfman LE, Assmann TS, Duarte GC, Canani LH, et al. The rs2292239 polymorphism in ERBB3 gene is associated with risk for type 1 diabetes mellitus in a Brazilian population. Gene. 2018;644:122-8. https://doi.org/10.1016/j.gene.2017.11.009

  38. Fukushima A, Loh K, Galic S, Fam B, Shields B, Wiede F, et al. T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis. Diabetes. 2010;59(8):1906-14. https://doi.org/10.2337/db09-1365

  39. Marroquí L, Santin I, Dos Santos RS, Marselli L, Marchetti P, Eizirik DL. BACH2, a candidate risk gene for type 1 diabetes, regulates apoptosis in pancreatic β-cells via JNK1 modulation and crosstalk with the candidate gene PTPN2. Diabetes. 2014;63(7):2516-27. https://doi.org/10.2337/db13-1443

  40. Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci U S A. 2008;105(37):14028-33. https://doi.org/10.1073/pnas.0804358105

  41. Brorsson CA, Pociot F. Shared genetic basis for type 1 diabetes, islet autoantibodies, and autoantibodies associated with other immune-mediated diseases in families with type 1 diabetes. Diabetes Care. 2015;38 Suppl 2(Suppl 2):S8-13. https://doi.org/10.2337/dcs15-2003

  42. Wallace C, Rotival M, Cooper JD, Rice CM, Yang JH, McNeill M, et al. Statistical colocalization of monocyte gene expression and genetic risk variants for type 1 diabetes. Hum Mol Genet. 2012;21(12):2815-24. https://doi.org/10.1093/hmg/dds098

  43. Fukaya M, Brorsson CA, Meyerovich K, Catrysse L, Delaroche D, Vanzela EC, et al. A20 inhibits β-cell apoptosis by multiple mechanisms and predicts residual β-cell function in type 1 diabetes. Mol Endocrinol. 2016;30(1):48-61. https://doi.org/10.1210/me.2015-1176

  44. Wallace C, Smyth DJ, Maisuria-Armer M, Walker NM, Todd JA, Clayton DG. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet. 2010;42(1):68-71. https://doi.org/10.1038/ng.493

  45. Dos Santos RS, Marroqui L, Velayos T, Olazagoitia-Garmendia A, Jauregi-Miguel A, Castellanos-Rubio A, et al. DEXI, a candidate gene for type 1 diabetes, modulates rat and human pancreatic beta cell inflammation via regulation of the type I IFN/STAT signalling pathway. Diabetologia. 2019;62(3):459-72. https://doi.org/10.1007/s00125-018-4782-0

  46. Zamani F, Almasi S, Kazemi T, Esfahlan RJ, Aliparasti MR. New approaches to the immunotherapy of type 1 diabetes mellitus using interleukin-27. Adv Pharm Bull. 2015;5(Suppl 1):599-603. https://doi.org/10.15171/apb.2015.081

  47. Costes S, Vandewalle B, Tourrel-Cuzin C, Broca C, Linck N, Bertrand G, et al. Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets. Diabetes. 2009;58(5):1105-15. https://doi.org/10.2337/db08-0926

  48. McKenzie MD, Jamieson E, Jansen ES, Scott CL, Huang DC, Bouillet P, et al. Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax. Diabetes. 2010;59(3):644-52. https://doi.org/10.2337/db09-1151

  49. Juntti-Berggren L, Refai E, Appelskog I, Andersson M, Imreh G, Dekki N, et al. Apolipoprotein CIII promotes Ca2+-dependent beta cell death in type 1 diabetes. Proc Natl Acad Sci U S A. 2004;101(27):10090-4. https://doi.org/10.1073/pnas.0403551101

  50. National Center for Biotechnology Information, U.S. National Library of Medicine. BAD BCL2 associated agonist of cell death [Homo sapiens (human)] [Internet]. Bethesda: National Center for Biotechnology Information, U.S. National Library of Medicine; 2018 [cited 2019 Mar 13]. Available from: https://www.ncbi.nlm.nih.gov/gene/572.

  51. Boyd CS, Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol Chem. 2002;383(3- 4):411-23. https://doi.org/10.1515/BC.2002.045

  52. Ishihara H, Sasaoka T, Kagawa S, Murakami S, Fukui K, Kawagishi Y, et al. Association of the polymorphisms in the 5'-untranslated region of PTEN gene with type 2 diabetes in a Japanese population. FEBS Lett. 2003:554(3):450-4. https://doi.org/10.1016/S0014-5793(03)01225-0

  53. Babu, SR, Bao F, Roberts CM, Martin AK, Gowan K, Eisenbarth GS, et al. Caspase 7 is a positional candidate gene for IDDM 17 in a Bedouin Arab family. Ann N Y Acad Sci. 2003;1005:340-3. https://doi.org/10.1196/annals.1288.054

  54. Berchtold LA, Størling ZM, Ortis, F, Lage K, Bang-Berthelsen C, Bergholdt R, et al. Huntingtin-interacting protein 14 is a type 1 diabetes candidate protein regulating insulin secretion and beta-cell apoptosis. Proc Natl Acad Sci U S A. 2011;108(37):E681-8. https://doi.org/10.1073/pnas.1104384108

  55. Weaver JR, Nadler JL, Taylor-Fishwick DA. Interleukin-12 (IL-12)/ STAT4 axis is an important element for β-Cell dysfunction induced by inflammatory cytokines. PLoS One. 2015;10(11):e0142735. https://doi.org/10.1371/journal.pone.0142735

  56. Cameron MJ, Arreaza GA, Grattan M, Meagher C, Sharif S, Burdick MD, et al. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type i diabetes. J Immunol, 2000;165(2):1102-10. https://doi.org/10.4049/jimmunol.165.2.1102

  57. Rorsman P, Ashcroft FM. Pancreatic β-cell electrical activity and insulin secretion: of mice and men. Physiol Rev. 98: 117-214. https://doi.org/10.1152/physrev.00008.2017

  58. Shoelson S, Haneda M, Blix P, Nanjo A, Sanke T, Inouye K, et al. Three mutant insulins in man. Nature. 1983;302(5908): 540-3. https://doi.org/10.1038/302540a0

  59. Genetics Home Reference. HNF1A gene [Internet]. Bethesda: National Center for Biotechnology Information, U.S. National Library of Medicine; 2018 [cited 2018 Jun 26]. Available from: https://ghr.nlm.nih.gov/gene/HNF1A#conditions.

  60. Santer R, Groth S, Kinner M, Dombrowski A, Berry GT, Brodehl J, et al. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum Genet. 2002;110(1):21-9. https://doi.org/10.1007/s00439-001-0638-6

  61. Götz J, Lim YA, Eckert A. Lessons from two prevalent amyloidoses-what amylin and Aβ have in common. Front Aging Neurosci. 2013;5:38. https://doi.org/10.3389/fnagi.2013.00038

  62. Gutiérrez GD, Bender AS, Cirulli V, Mastracci TL, Kelly SM, Tsirigos A, et al. Pancreatic β cell identity requires continual repression of non–β cell programs. Clin Invest. 2017;127(1):244-59. https://doi.org/10.1172/JCI88017

  63. Wen X, Yang Y. Emerging roles of GLIS3 in neonatal diabetes, type 1 and type 2 diabetes. J Mol Endocrinol. 2017;58(2):R73-85. https://doi.org/10.1530/JME-16-0232

  64. Romer AI, Singer RA, Sui L, Egli D, Sussel L. Murine perinatal β-cell proliferation and the differentiation of human stem cell-derived insulin-expressing cells require NEUROD1. Diabetes. 2019;68(12):2259-71. https://doi.org/10.2337/db19-0117

  65. Fløyel T, Brorsson C, Nielsen LB, Miani M, Bang-Berthelsen CH, Friedrichsen M, et al. CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients. Proc Natl Acad Sci U S A. 2014;111(28):10305-10. https://doi.org/10.1073/pnas.1402571111

  66. Santos MA, Sarmento LM, Rebelo M, Doce AA, Maillard I, Dumortier A, et al. Notch1 engagement by delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells. Proc Natl Acad Sci U S A. 2007;104(39):15454-9. https://doi.org/10.1073/pnas.0702891104

  67. Holm LJ, Krogvold L, Hasselby JP, Kaur S, Claessens LA, Russell MA, et al. Abnormal islet sphingolipid metabolism in type 1 diabetes. Diabetologia. 2018;61:1650-61. https://doi.org/10.1007/s00125-018-4614-2

  68. Rachdi L, Balcazar N, Elghazi L, Barker DJ, Krits I, Kiyokawa H, et al. Differential effects of p27 in regulation of β-cell mass during development, neonatal period, and adult life. Diabetes. 2006;55(12):3520-8. https://doi.org/10.2337/db06-0861

  69. Kulkarni RN. New insights into the roles of insulin/IGF-I in the development and maintenance of beta-cell mass. Rev Endocr Metab Disord. 2005;6(3):199-210. https://doi.org/10.1007/s11154-005-3051-y

  70. Dendrou CA, Wicker LS. The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice. J Clin Immunol. 2008;28(60):685-96. https://doi.org/10.1007/s10875-008-9237-9

  71. Genetics Home Reference. Histocompatibility complex [Intenet]. Bethesda: National Center for Biotechnology Information, U.S. National Library of Medicine; 2018 [cited 2018 Jun 26]. Available from: https://ghr.nlm.nih.gov/primer/genefamily/hla.

  72. Notkins AL. Immunologic and genetic factors in type 1 diabetes. J Biol Chem. 2002:277(46):43545-8. https://doi.org/10.1074/jbc.R200012200

  73. National Center for Biotechnology Information, U.S. National Library of Medicine. INS insulin [Homo sapiens (human)] [Internet]. Bethesda: National Center for Biotechnology Information, U.S. National Library of Medicine; 2018 [cited 2018 Jun 27]. Available from: https://www.ncbi.nlm.nih.gov/gene/3630#gene-expression.

  74. Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, et al. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes. 2005;54(10):2995-3001. https://doi.org/10.2337/diabetes.54.10.2995

  75. Kantárová D, Buc M. Genetic susceptibility to type 1 diabetes mellitus in humans. Physiol Res. 2007;56(3):255-66.

  76. Sharp RC, Abdulrahim M, Naser ES, Naser SA. Genetic variations of PTPN2 and PTPN22: role in the pathogenesis of type 1 diabetes and Crohn's disease. Front Cell Infect Microbiol. 2015;5:95. https://doi.org/10.3389/fcimb.2015.00095

  77. Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem. 2011;57(2):176-85. https://doi.org/10.1373/clinchem.2010.148221

  78. Bingley PJ, Bonifacio E, Ziegler AG, Schatz DA, Atkinson MA, Eisenbarth GS, et al. Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care. 2001;24(2):398. https://doi.org/10.2337/diacare.24.2.398

  79. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163-89. https://doi.org/10.1189/jlb.0603252

Published
2020-03-26
How to Cite
1.
Yahaya T, Salisu T. Genes predisposing to type 1 diabetes mellitus and pathophysiology: a narrative review. Med J Indones [Internet]. 2020Mar.26 [cited 2024Apr.25];29(1):100-9. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/3732
Issue
Vol. 29 No. 1 (2020): March
Section
Review Article

Copyright (c) 2020 Tajudeen Yahaya, Titilola Salisu

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.

DB Error: You have an error in your SQL syntax; check the manual that corresponds to your MySQL server version for the right syntax to use near ') AND metric_type = 'ojs::counter' GROUP BY submission_id ORDER BY metric DESC' at line 1

Stack Trace:

File: /home/mjifkui/public/journal/lib/pkp/classes/statistics/PKPMetricsDAO.inc.php line 192
Function: DAO->retrieve("SELECT submission_id, SUM(metric) AS metric FROM metrics WHERE a...", Array(3))

File: /home/mjifkui/public/journal/classes/statistics/MetricsDAO.inc.php line 39
Function: PKPMetricsDAO->getMetrics(Array(1), Array(1), Array(3), Array(1), Null, True)

File: /home/mjifkui/public/journal/plugins/generic/usageStats/PKPUsageStatsReportPlugin.inc.php line 84
Function: MetricsDAO->getMetrics("ojs::counter", Array(1), Array(2), Array(1), Null)

File: /home/mjifkui/public/journal/plugins/generic/usageStats/OJSUsageStatsReportPlugin.inc.php line 32
Function: PKPUsageStatsReportPlugin->getMetrics("ojs::counter", Array(1), Array(2), Array(1), Null)

File: /home/mjifkui/public/journal/lib/pkp/classes/core/PKPApplication.inc.php line 615
Function: OJSUsageStatsReportPlugin->getMetrics("ojs::counter", Array(1), Array(2), Array(1), Null)

File: /home/mjifkui/public/journal/plugins/generic/recommendByAuthor/RecommendByAuthorPlugin.inc.php line 96
Function: PKPApplication->getMetrics(Array(1), Array(1), Array(2), Array(1))

File: /home/mjifkui/public/journal/lib/pkp/classes/plugins/HookRegistry.inc.php line 107
Function: RecommendByAuthorPlugin->callbackTemplateArticlePageFooter("Templates::Article::Footer::PageFooter", Array(3))

File: /home/mjifkui/public/journal/lib/pkp/classes/template/PKPTemplateManager.inc.php line 1116
Function: HookRegistry::call("Templates::Article::Footer::PageFooter", Array(3))

File: /home/mjifkui/public/journal/cache/t_compile/42362804174f266c598cdb32c3208fc745b92101^1c372c95cd85572e0fbc9a53d0323a0b229cfc78_0.app.frontendpagesarticle.tpl.php line 43
Function: PKPTemplateManager->smartyCallHook(Array(1), Object(Smarty_Internal_Template))

File: /home/mjifkui/public/journal/lib/pkp/lib/vendor/smarty/smarty/libs/sysplugins/smarty_template_resource_base.php line 123
Function: content_661e2adf5094a4_83632276(Object(Smarty_Internal_Template))

File: /home/mjifkui/public/journal/lib/pkp/lib/vendor/smarty/smarty/libs/sysplugins/smarty_template_compiled.php line 114
Function: Smarty_Template_Resource_Base->getRenderedTemplateCode(Object(Smarty_Internal_Template))

File: /home/mjifkui/public/journal/lib/pkp/lib/vendor/smarty/smarty/libs/sysplugins/smarty_internal_template.php line 216
Function: Smarty_Template_Compiled->render(Object(Smarty_Internal_Template))

File: /home/mjifkui/public/journal/lib/pkp/lib/vendor/smarty/smarty/libs/sysplugins/smarty_internal_templatebase.php line 232
Function: Smarty_Internal_Template->render(False, 1)

File: /home/mjifkui/public/journal/lib/pkp/lib/vendor/smarty/smarty/libs/sysplugins/smarty_internal_templatebase.php line 134
Function: Smarty_Internal_TemplateBase->_execute(Object(Smarty_Internal_Template), Null, "42362804174f266c598cdb32c3208fc745b92101", Null, 1)

File: /home/mjifkui/public/journal/lib/pkp/classes/template/PKPTemplateManager.inc.php line 843
Function: Smarty_Internal_TemplateBase->display("frontend/pages/article.tpl", Null, "42362804174f266c598cdb32c3208fc745b92101", Null)

File: /home/mjifkui/public/journal/pages/article/ArticleHandler.inc.php line 216
Function: PKPTemplateManager->display("frontend/pages/article.tpl")

File: /home/mjifkui/public/journal/lib/pkp/classes/core/PKPRouter.inc.php line 390
Function: ArticleHandler->view(Array(0), Object(Request))

File: /home/mjifkui/public/journal/lib/pkp/classes/core/PKPPageRouter.inc.php line 231
Function: PKPRouter->_authorizeInitializeAndCallRequest(Array(2), Object(Request), Array(1), False)

File: /home/mjifkui/public/journal/lib/pkp/classes/core/Dispatcher.inc.php line 134
Function: PKPPageRouter->route(Object(Request))

File: /home/mjifkui/public/journal/lib/pkp/classes/core/PKPApplication.inc.php line 252
Function: Dispatcher->dispatch(Object(Request))

File: /home/mjifkui/public/journal/index.php line 68
Function: PKPApplication->execute()